Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
CRISPR–Cas9 genome editing is used to correct a dominant-negative mutation in a mouse model of inherited deafness, resulting in improvements in cochlear function and hearing. Hindering heritable hearing loss Nearly half of all deafness cases arise from genetic factors, yet there are limited treatmen...
Saved in:
Published in | Nature (London) Vol. 553; no. 7687; pp. 217 - 221 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
11.01.2018
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | CRISPR–Cas9 genome editing is used to correct a dominant-negative mutation in a mouse model of inherited deafness, resulting in improvements in cochlear function and hearing.
Hindering heritable hearing loss
Nearly half of all deafness cases arise from genetic factors, yet there are limited treatment options available for inherited hearing loss. David Liu and colleagues develop a genome-editing approach to target a dominantly inherited form of deafness. In a mouse model of human deafness, CRISPR–Cas9 editing can disrupt the mutant allele and reduce hearing loss. The results support the potential utility of protein–RNA complex delivery in post-mitotic cells as a gene-editing strategy for some autosomal-dominant diseases.
Although genetic factors contribute to almost half of all cases of deafness, treatment options for genetic deafness are limited
1
,
2
,
3
,
4
,
5
. We developed a genome-editing approach to target a dominantly inherited form of genetic deafness. Here we show that cationic lipid-mediated
in vivo
delivery of Cas9–guide RNA complexes can ameliorate hearing loss in a mouse model of human genetic deafness. We designed and validated, both
in vitro
and in primary fibroblasts, genome editing agents that preferentially disrupt the dominant deafness-associated allele in the
Tmc1
(transmembrane channel-like gene family 1) Beethoven (
Bth
) mouse model, even though the mutant
Tmc1
Bth
allele differs from the wild-type allele at only a single base pair. Injection of Cas9–guide RNA–lipid complexes targeting the
Tmc1
Bth
allele into the cochlea of neonatal
Tmc1
Bth
/+
mice substantially reduced progressive hearing loss. We observed higher hair cell survival rates and lower auditory brainstem response thresholds in injected ears than in uninjected ears or ears injected with control complexes that targeted an unrelated gene. Enhanced acoustic startle responses were observed among injected compared to uninjected
Tmc1
Bth
/+
mice. These findings suggest that protein–RNA complex delivery of target gene-disrupting agents
in vivo
is a potential strategy for the treatment of some types of autosomal-dominant hearing loss. |
---|---|
AbstractList | Although genetic factors contribute to almost half of all cases of deafness, treatment options for genetic deafness are limited. We developed a genome-editing approach to target a dominantly inherited form of genetic deafness. Here we show that cationic lipid-mediated in vivo delivery of Cas9-guide RNA complexes can ameliorate hearing loss in a mouse model of human genetic deafness. We designed and validated, both in vitro and in primary fibroblasts, genome editing agents that preferentially disrupt the dominant deafness-associated allele in the Tmc1 (transmembrane channel-like gene family 1) Beethoven (Bth) mouse model, even though the mutant Tmc1
allele differs from the wild-type allele at only a single base pair. Injection of Cas9-guide RNA-lipid complexes targeting the Tmc1
allele into the cochlea of neonatal Tmc1
mice substantially reduced progressive hearing loss. We observed higher hair cell survival rates and lower auditory brainstem response thresholds in injected ears than in uninjected ears or ears injected with control complexes that targeted an unrelated gene. Enhanced acoustic startle responses were observed among injected compared to uninjected Tmc1
mice. These findings suggest that protein-RNA complex delivery of target gene-disrupting agents in vivo is a potential strategy for the treatment of some types of autosomal-dominant hearing loss. Although genetic factors contribute to almost half of all cases of deafness, treatment options for genetic deafness are limited1-5. We developed a genome-editing approach to target a dominantly inherited form of genetic deafness. Here we show that cationic lipid-mediated in vivo delivery of Cas9-guide RNA complexes can ameliorate hearing loss in a mouse model of human genetic deafness. We designed and validated, both in vitro and in primary fibroblasts, genome editing agents that preferentially disrupt the dominant deafness-associated allele in the Tmcl (transmembrane channel-like gene family 1) Beethoven (Bth) mouse model, even though the mutant Tmc1Bth allele differs from the wild-type allele at only a single base pair. Injection of Cas9-guide RNA-lipid complexes targeting the Tmc1Bth allele into the cochlea of neonatal Tmc1Bth/+ mice substantially reduced progressive hearing loss. We observed higher hair cell survival rates and lower auditory brainstem response thresholds in injected ears than in uninjected ears or ears injected with control complexes that targeted an unrelated gene. Enhanced acoustic startle responses were observed among injected compared to uninjected Tmc1Bth/+ mice. These findings suggest that protein-RNA complex delivery of target gene-disrupting agents in vivo is a potential strategy for the treatment of some types of autosomal-dominant hearing loss. Although genetic factors contribute to almost half of all cases of deafness, treatment options for genetic deafness are limited. We developed a genome-editing approach to target a dominantly inherited form of genetic deafness. Here we show that cationic lipid-mediated in vivo delivery of Cas9-guide RNA complexes can ameliorate hearing loss in a mouse model of human genetic deafness. We designed and validated, both in vitro and in primary fibroblasts, genome editing agents that preferentially disrupt the dominant deafness-associated allele in the Tmc1 (transmembrane channel-like gene family 1) Beethoven (Bth) mouse model, even though the mutant Tmc1Bth allele differs from the wild-type allele at only a single base pair. Injection of Cas9-guide RNA-lipid complexes targeting the Tmc1Bth allele into the cochlea of neonatal Tmc1Bth/+ mice substantially reduced progressive hearing loss. We observed higher hair cell survival rates and lower auditory brainstem response thresholds in injected ears than in uninjected ears or ears injected with control complexes that targeted an unrelated gene. Enhanced acoustic startle responses were observed among injected compared to uninjected Tmc1Bth/+ mice. These findings suggest that protein-RNA complex delivery of target gene-disrupting agents in vivo is a potential strategy for the treatment of some types of autosomal-dominant hearing loss.Although genetic factors contribute to almost half of all cases of deafness, treatment options for genetic deafness are limited. We developed a genome-editing approach to target a dominantly inherited form of genetic deafness. Here we show that cationic lipid-mediated in vivo delivery of Cas9-guide RNA complexes can ameliorate hearing loss in a mouse model of human genetic deafness. We designed and validated, both in vitro and in primary fibroblasts, genome editing agents that preferentially disrupt the dominant deafness-associated allele in the Tmc1 (transmembrane channel-like gene family 1) Beethoven (Bth) mouse model, even though the mutant Tmc1Bth allele differs from the wild-type allele at only a single base pair. Injection of Cas9-guide RNA-lipid complexes targeting the Tmc1Bth allele into the cochlea of neonatal Tmc1Bth/+ mice substantially reduced progressive hearing loss. We observed higher hair cell survival rates and lower auditory brainstem response thresholds in injected ears than in uninjected ears or ears injected with control complexes that targeted an unrelated gene. Enhanced acoustic startle responses were observed among injected compared to uninjected Tmc1Bth/+ mice. These findings suggest that protein-RNA complex delivery of target gene-disrupting agents in vivo is a potential strategy for the treatment of some types of autosomal-dominant hearing loss. Although genetic factors contribute to almost half of all deafness cases, treatment options for genetic deafness are limited 1 – 5 . We developed a genome editing approach to target a dominantly inherited form of genetic deafness. Here we show that cationic lipid-mediated in vivo delivery of Cas9:guide RNA complexes can ameliorate hearing loss in a mouse model of human genetic deafness. We designed and validated in vitro and in primary fibroblasts genome editing agents that preferentially disrupt the dominant deafness-associated allele in the Tmc1 (transmembrane channel-like 1) Beethoven ( Bth ) mouse model, even though the mutant Bth allele differs from the wild-type allele at only a single base pair. Injection of Cas9:guide RNA:lipid complexes targeting the Bth allele into the cochlea of neonatal Bth/+ mice substantially reduced progressive hearing loss. We observed higher hair cell survival rates and lower auditory brainstem response (ABR) thresholds in injected ears compared with uninjected ears or ears injected with complexes that target an unrelated gene. Enhanced acoustic reflex responses were observed among injected compared to uninjected Bth/+ animals. These findings suggest protein:RNA complex delivery of target gene-disrupting agents in vivo as a potential strategy for the treatment of some autosomal dominant hearing loss diseases. CRISPR–Cas9 genome editing is used to correct a dominant-negative mutation in a mouse model of inherited deafness, resulting in improvements in cochlear function and hearing. Hindering heritable hearing loss Nearly half of all deafness cases arise from genetic factors, yet there are limited treatment options available for inherited hearing loss. David Liu and colleagues develop a genome-editing approach to target a dominantly inherited form of deafness. In a mouse model of human deafness, CRISPR–Cas9 editing can disrupt the mutant allele and reduce hearing loss. The results support the potential utility of protein–RNA complex delivery in post-mitotic cells as a gene-editing strategy for some autosomal-dominant diseases. Although genetic factors contribute to almost half of all cases of deafness, treatment options for genetic deafness are limited 1 , 2 , 3 , 4 , 5 . We developed a genome-editing approach to target a dominantly inherited form of genetic deafness. Here we show that cationic lipid-mediated in vivo delivery of Cas9–guide RNA complexes can ameliorate hearing loss in a mouse model of human genetic deafness. We designed and validated, both in vitro and in primary fibroblasts, genome editing agents that preferentially disrupt the dominant deafness-associated allele in the Tmc1 (transmembrane channel-like gene family 1) Beethoven ( Bth ) mouse model, even though the mutant Tmc1 Bth allele differs from the wild-type allele at only a single base pair. Injection of Cas9–guide RNA–lipid complexes targeting the Tmc1 Bth allele into the cochlea of neonatal Tmc1 Bth /+ mice substantially reduced progressive hearing loss. We observed higher hair cell survival rates and lower auditory brainstem response thresholds in injected ears than in uninjected ears or ears injected with control complexes that targeted an unrelated gene. Enhanced acoustic startle responses were observed among injected compared to uninjected Tmc1 Bth /+ mice. These findings suggest that protein–RNA complex delivery of target gene-disrupting agents in vivo is a potential strategy for the treatment of some types of autosomal-dominant hearing loss. |
Audience | Academic |
Author | Lamas, Veronica Holt, Jeffrey R. Huang, Mingqian Thompson, David B. Kong, Wei-Jia Liu, David R. Gao, Xue Yeh, Wei-Hsi Liberman, M. Charles Polley, Daniel B. Hu, Yu-Juan Li, Yamin Wang, Hongyang Pan, Bifeng Xu, Qiaobing Chen, Zheng-Yi Tao, Yong Yang, Shiming Hu, Johnny H. Shu, Yilai |
AuthorAffiliation | 5 Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China 4 Department of Otolaryngology and Program in Neuroscience, Harvard Medical School and Eaton Peabody Laboratory, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts 02114, USA 9 Department of Biomedical Engineering, Tufts University, Medford, MA 02155, USA 7 Departments of Otolaryngology and Neurology, F.M. Kirby Neurobiology Center Boston Children’s Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA 8 Department of Otolaryngology–Head and Neck Surgery, Eye and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China 3 Broad Institute of MIT and Harvard, Cambridge, MA, 02141, USA 6 Program in Speech and Hearing Bioscience and Technology, Harvard University, Cambridge, Massachusetts 02138, USA 2 Howard Hughes Medical Institute, Harvard University, Cambridge, MA, 02138, USA 10 Department of Otolaryngolog |
AuthorAffiliation_xml | – name: 1 Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, 02138, USA – name: 3 Broad Institute of MIT and Harvard, Cambridge, MA, 02141, USA – name: 2 Howard Hughes Medical Institute, Harvard University, Cambridge, MA, 02138, USA – name: 4 Department of Otolaryngology and Program in Neuroscience, Harvard Medical School and Eaton Peabody Laboratory, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts 02114, USA – name: 10 Department of Otolaryngology & Head Neck Surgery, Key Lab of Hearing Impairment Science of Ministry of Education, Key Lab of Hearing Impairment Prevention and Treatment of Beijing City, Chinese PLA Medical School, Beijing, China – name: 6 Program in Speech and Hearing Bioscience and Technology, Harvard University, Cambridge, Massachusetts 02138, USA – name: 9 Department of Biomedical Engineering, Tufts University, Medford, MA 02155, USA – name: 5 Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China – name: 7 Departments of Otolaryngology and Neurology, F.M. Kirby Neurobiology Center Boston Children’s Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA – name: 8 Department of Otolaryngology–Head and Neck Surgery, Eye and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China |
Author_xml | – sequence: 1 givenname: Xue surname: Gao fullname: Gao, Xue organization: Department of Chemistry and Chemical Biology, Harvard University, Howard Hughes Medical Institute, Harvard University, Broad Institute of MIT and Harvard, Department of Chemical and Biomolecular Engineering, Rice University – sequence: 2 givenname: Yong surname: Tao fullname: Tao, Yong organization: Department of Otolaryngology and Program in Neuroscience, Harvard Medical School and Eaton Peabody Laboratory, Massachusetts Eye and Ear Infirmary, Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Department of Otolaryngology-Head and Neck Surgery, Shanghai Ninth People’s Hospital and Ear Institute, Shanghai Jiaotong University School of Medicine – sequence: 3 givenname: Veronica surname: Lamas fullname: Lamas, Veronica organization: Department of Otolaryngology and Program in Neuroscience, Harvard Medical School and Eaton Peabody Laboratory, Massachusetts Eye and Ear Infirmary – sequence: 4 givenname: Mingqian surname: Huang fullname: Huang, Mingqian organization: Department of Otolaryngology and Program in Neuroscience, Harvard Medical School and Eaton Peabody Laboratory, Massachusetts Eye and Ear Infirmary – sequence: 5 givenname: Wei-Hsi surname: Yeh fullname: Yeh, Wei-Hsi organization: Department of Chemistry and Chemical Biology, Harvard University, Howard Hughes Medical Institute, Harvard University, Broad Institute of MIT and Harvard, Program in Speech and Hearing Bioscience and Technology, Harvard University – sequence: 6 givenname: Bifeng surname: Pan fullname: Pan, Bifeng organization: Departments of Otolaryngology and Neurology, F.M. Kirby Neurobiology Center Boston Children’s Hospital and Harvard Medical School – sequence: 7 givenname: Yu-Juan surname: Hu fullname: Hu, Yu-Juan organization: Department of Otolaryngology and Program in Neuroscience, Harvard Medical School and Eaton Peabody Laboratory, Massachusetts Eye and Ear Infirmary, Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology – sequence: 8 givenname: Johnny H. surname: Hu fullname: Hu, Johnny H. organization: Department of Chemistry and Chemical Biology, Harvard University, Howard Hughes Medical Institute, Harvard University, Broad Institute of MIT and Harvard – sequence: 9 givenname: David B. surname: Thompson fullname: Thompson, David B. organization: Department of Chemistry and Chemical Biology, Harvard University, Howard Hughes Medical Institute, Harvard University – sequence: 10 givenname: Yilai surname: Shu fullname: Shu, Yilai organization: Department of Otolaryngology and Program in Neuroscience, Harvard Medical School and Eaton Peabody Laboratory, Massachusetts Eye and Ear Infirmary, Department of Otolaryngology–Head and Neck Surgery, Eye and ENT Hospital, Shanghai Medical College, Fudan University – sequence: 11 givenname: Yamin surname: Li fullname: Li, Yamin organization: Department of Biomedical Engineering, Tufts University – sequence: 12 givenname: Hongyang surname: Wang fullname: Wang, Hongyang organization: Department of Otolaryngology and Program in Neuroscience, Harvard Medical School and Eaton Peabody Laboratory, Massachusetts Eye and Ear Infirmary, Department of Otolaryngology & Head Neck Surgery, Key Lab of Hearing Impairment Science of Ministry of Education, Key Lab of Hearing Impairment Prevention and Treatment of Beijing City, Chinese PLA Medical School – sequence: 13 givenname: Shiming surname: Yang fullname: Yang, Shiming organization: Department of Otolaryngology & Head Neck Surgery, Key Lab of Hearing Impairment Science of Ministry of Education, Key Lab of Hearing Impairment Prevention and Treatment of Beijing City, Chinese PLA Medical School – sequence: 14 givenname: Qiaobing surname: Xu fullname: Xu, Qiaobing organization: Department of Biomedical Engineering, Tufts University – sequence: 15 givenname: Daniel B. surname: Polley fullname: Polley, Daniel B. organization: Department of Otolaryngology and Program in Neuroscience, Harvard Medical School and Eaton Peabody Laboratory, Massachusetts Eye and Ear Infirmary – sequence: 16 givenname: M. Charles surname: Liberman fullname: Liberman, M. Charles organization: Department of Otolaryngology and Program in Neuroscience, Harvard Medical School and Eaton Peabody Laboratory, Massachusetts Eye and Ear Infirmary – sequence: 17 givenname: Wei-Jia surname: Kong fullname: Kong, Wei-Jia organization: Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology – sequence: 18 givenname: Jeffrey R. surname: Holt fullname: Holt, Jeffrey R. organization: Departments of Otolaryngology and Neurology, F.M. Kirby Neurobiology Center Boston Children’s Hospital and Harvard Medical School – sequence: 19 givenname: Zheng-Yi surname: Chen fullname: Chen, Zheng-Yi email: Zheng-Yi_Chen@meei.harvard.edu organization: Department of Otolaryngology and Program in Neuroscience, Harvard Medical School and Eaton Peabody Laboratory, Massachusetts Eye and Ear Infirmary – sequence: 20 givenname: David R. surname: Liu fullname: Liu, David R. email: drliu@fas.harvard.edu organization: Department of Chemistry and Chemical Biology, Harvard University, Howard Hughes Medical Institute, Harvard University, Broad Institute of MIT and Harvard |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29258297$$D View this record in MEDLINE/PubMed |
BookMark | eNp10ktr3DAQAGBRUppN2lPvxTSXlNapXpbsSyGEPgKBQpseehJaebxRsKWNJC_dfx-ZTdPdsMUHY_mbkTQzR-jAeQcIvSb4jGBWf3Q6jQFoRQR_hmaES1FyUcsDNMOY1iWumThERzHeYowrIvkLdEgbWtW0kTP0-zqATgO4VPiu0GPy0Q-6L1o_WKfz6g3oYN2i6H2MxXxdWFes7MoXLfR2BWE9hS3A-QEKaG2aqM7fKb5EzzvdR3j18D5Gv758vr74Vl59_3p5cX5VGiHrVEJDGjKfU4m5MIBbhgUIbDhjc6IFb3UrCBECGt41rNOYSyx0JxmRujOMGnaMPm3yLsf5AK3Jewfdq2Wwgw5r5bVVu3-cvVELv1KVrDkVMic4fUgQ_N0IManBRgN9rx34MSrSyIZIUlU005Mn9NaPweXrZVVLlhWp_qmF7kFZ1_m8r5mSqvOKUtbQWvKsyj0qlw7yIXOHO5uXd_zbPd4s7Z3aRmd7UH5aGKzZm_XdTkA2Cf6khR5jVJc_f-zaN9uVfizx32nK4P0GmJCnJUD3SAhW06yqrVnNmjzRxiadrJ_aZPv_xHzYxMTlNJUQthqwh98DnNn5sw |
CitedBy_id | crossref_primary_10_1002_smll_202309431 crossref_primary_10_1016_j_ymthe_2020_07_021 crossref_primary_10_2183_pjab_96_002 crossref_primary_10_1016_j_heares_2020_107958 crossref_primary_10_1242_dev_177188 crossref_primary_10_2174_1566523219666190701100556 crossref_primary_10_1002_adfm_202418090 crossref_primary_10_3389_fnins_2022_867453 crossref_primary_10_1007_s10544_018_0292_6 crossref_primary_10_3389_fcell_2023_1305433 crossref_primary_10_3390_ijms21051597 crossref_primary_10_1038_s41573_018_0009_9 crossref_primary_10_1002_advs_202410494 crossref_primary_10_3389_fbioe_2020_00692 crossref_primary_10_1016_j_ymthe_2024_11_012 crossref_primary_10_3389_fnins_2021_652215 crossref_primary_10_1016_j_biomaterials_2022_121876 crossref_primary_10_1097_JBR_0000000000000112 crossref_primary_10_26599_NBE_2024_9290096 crossref_primary_10_1371_journal_pbio_3002071 crossref_primary_10_3389_fncel_2019_00323 crossref_primary_10_1038_s41591_019_0346_1 crossref_primary_10_7554_eLife_77825 crossref_primary_10_1038_s41596_024_01043_6 crossref_primary_10_1097_MOL_0000000000000591 crossref_primary_10_1038_s41434_020_0124_1 crossref_primary_10_1186_s13059_019_1783_3 crossref_primary_10_1038_s41587_020_0565_5 crossref_primary_10_1007_s00106_019_0613_y crossref_primary_10_1007_s40136_022_00427_0 crossref_primary_10_1016_j_copbio_2018_03_007 crossref_primary_10_1016_j_ymthe_2023_05_005 crossref_primary_10_4252_wjsc_v12_i6_422 crossref_primary_10_1186_s40246_023_00507_2 crossref_primary_10_1146_annurev_genom_121321_094136 crossref_primary_10_3390_biom12050649 crossref_primary_10_1016_j_matbio_2018_03_010 crossref_primary_10_1158_0008_5472_CAN_18_0571 crossref_primary_10_1080_20415990_2024_2389032 crossref_primary_10_1016_j_pmatsci_2022_101014 crossref_primary_10_1080_01478885_2018_1470133 crossref_primary_10_3390_genes15020178 crossref_primary_10_3390_jcm9072309 crossref_primary_10_3390_cells11203331 crossref_primary_10_1016_j_omtn_2021_04_009 crossref_primary_10_1016_j_scib_2024_06_012 crossref_primary_10_1007_s11033_020_05460_0 crossref_primary_10_1016_j_synbio_2018_10_003 crossref_primary_10_1126_sciadv_abb4005 crossref_primary_10_1242_dev_168906 crossref_primary_10_1038_s41551_018_0267_1 crossref_primary_10_1089_hum_2024_191 crossref_primary_10_1021_acsami_9b21667 crossref_primary_10_1002_lio2_390 crossref_primary_10_1044_2020_PERSP_20_00072 crossref_primary_10_3390_biom13010038 crossref_primary_10_1016_j_addr_2020_09_004 crossref_primary_10_1016_j_heares_2020_107934 crossref_primary_10_1002_advs_202400469 crossref_primary_10_1016_j_heares_2020_107932 crossref_primary_10_1038_s41591_018_0338_6 crossref_primary_10_2147_IJN_S315444 crossref_primary_10_1002_advs_202401797 crossref_primary_10_1016_j_heares_2020_107931 crossref_primary_10_1016_j_stem_2019_05_008 crossref_primary_10_1038_s41422_019_0213_0 crossref_primary_10_1080_17435889_2025_2457781 crossref_primary_10_1042_BSR20200127 crossref_primary_10_1038_s41576_024_00809_8 crossref_primary_10_1007_s12033_022_00501_4 crossref_primary_10_3389_fcell_2019_00014 crossref_primary_10_1007_s12033_023_00724_z crossref_primary_10_1016_j_ymthe_2019_03_017 crossref_primary_10_3389_fncel_2021_660748 crossref_primary_10_1371_journal_pone_0200210 crossref_primary_10_1016_j_nantod_2022_101482 crossref_primary_10_1093_nar_gkaa194 crossref_primary_10_7874_jao_2024_00157 crossref_primary_10_3390_biom13101534 crossref_primary_10_1007_s12010_023_04708_2 crossref_primary_10_1016_j_heares_2020_107947 crossref_primary_10_1016_j_chembiol_2018_10_025 crossref_primary_10_1016_j_genrep_2020_100983 crossref_primary_10_1038_s41467_018_07322_7 crossref_primary_10_1016_j_jbiotec_2019_11_010 crossref_primary_10_1016_j_heares_2018_05_009 crossref_primary_10_3390_genes11101113 crossref_primary_10_1007_s11427_021_2057_0 crossref_primary_10_1007_s11756_023_01454_y crossref_primary_10_29296_24999490_2024_06_04 crossref_primary_10_3389_fncel_2021_728610 crossref_primary_10_1007_s00109_020_01893_z crossref_primary_10_1016_j_apsb_2022_04_013 crossref_primary_10_1016_j_heares_2018_05_002 crossref_primary_10_1016_j_ymeth_2021_06_004 crossref_primary_10_3389_fncel_2019_00529 crossref_primary_10_1038_s41573_020_0075_7 crossref_primary_10_1007_s13238_020_00704_y crossref_primary_10_1186_s43556_022_00095_y crossref_primary_10_1016_j_heares_2019_107858 crossref_primary_10_3390_pharmaceutics14091842 crossref_primary_10_1126_scitranslmed_abn0449 crossref_primary_10_1080_02648725_2021_1962071 crossref_primary_10_3389_fauot_2024_1423853 crossref_primary_10_1016_j_otorri_2020_06_009 crossref_primary_10_1016_j_trecan_2018_05_006 crossref_primary_10_23736_S2724_6302_21_02381_1 crossref_primary_10_1016_j_tins_2023_02_005 crossref_primary_10_1016_j_bioactmat_2022_01_011 crossref_primary_10_1097_JBR_0000000000000108 crossref_primary_10_3390_ijms22083910 crossref_primary_10_1038_s41598_022_07746_8 crossref_primary_10_1016_j_biomaterials_2023_122133 crossref_primary_10_1016_j_neulet_2019_134326 crossref_primary_10_1021_jacs_9b09043 crossref_primary_10_1002_adtp_202000178 crossref_primary_10_1021_acs_bioconjchem_8b00856 crossref_primary_10_1038_s41419_023_05899_6 crossref_primary_10_1016_j_ymthe_2020_10_005 crossref_primary_10_1186_s12951_021_01233_4 crossref_primary_10_1016_j_actbio_2024_10_030 crossref_primary_10_1016_j_biochi_2023_05_011 crossref_primary_10_1016_j_ymthe_2021_06_015 crossref_primary_10_1016_j_ymthe_2021_06_016 crossref_primary_10_1016_j_addr_2020_05_001 crossref_primary_10_3390_jcm9020589 crossref_primary_10_3389_fnins_2020_579062 crossref_primary_10_3390_biomedicines11123347 crossref_primary_10_1038_s41592_023_01875_2 crossref_primary_10_3389_fnmol_2022_1028125 crossref_primary_10_1126_scitranslmed_aay9101 crossref_primary_10_1016_j_omtm_2021_03_005 crossref_primary_10_1164_rccm_201711_2242OC crossref_primary_10_1089_hum_2023_126 crossref_primary_10_2174_1574888X17666220429121714 crossref_primary_10_1126_sciadv_abo6405 crossref_primary_10_1038_s41467_023_40476_7 crossref_primary_10_1089_crispr_2020_0025 crossref_primary_10_1186_s13287_018_0967_1 crossref_primary_10_1097_JBR_0000000000000040 crossref_primary_10_1186_s13578_023_01021_7 crossref_primary_10_1002_cbic_202400596 crossref_primary_10_1038_s41467_019_12922_y crossref_primary_10_1038_s41477_021_00991_1 crossref_primary_10_1038_s41586_018_0500_9 crossref_primary_10_1016_j_heares_2024_109130 crossref_primary_10_1002_anie_201903618 crossref_primary_10_1016_j_apmt_2022_101488 crossref_primary_10_1016_j_fmre_2022_08_015 crossref_primary_10_1016_j_ymthe_2023_06_007 crossref_primary_10_1038_s41586_020_1978_5 crossref_primary_10_1039_C8BM00637G crossref_primary_10_35420_jcohns_2021_32_1_5 crossref_primary_10_1038_s41551_022_00847_9 crossref_primary_10_1016_j_colsurfb_2023_113612 crossref_primary_10_1016_j_omtn_2022_07_016 crossref_primary_10_1159_000515845 crossref_primary_10_1186_s12951_025_03254_9 crossref_primary_10_1186_s13059_021_02311_4 crossref_primary_10_1007_s12033_022_00479_z crossref_primary_10_1038_s41434_023_00431_z crossref_primary_10_1002_cpz1_76 crossref_primary_10_1111_trf_15126 crossref_primary_10_1007_s40136_020_00300_y crossref_primary_10_1016_j_canlet_2019_04_040 crossref_primary_10_1016_j_addr_2021_114087 crossref_primary_10_1016_j_jconrel_2024_08_030 crossref_primary_10_1085_jgp_202413585 crossref_primary_10_1002_ange_201903618 crossref_primary_10_1016_j_scr_2022_102736 crossref_primary_10_1038_s41586_019_1711_4 crossref_primary_10_1126_scitranslmed_adn0689 crossref_primary_10_1038_d41586_017_08645_z crossref_primary_10_1016_j_celrep_2020_02_068 crossref_primary_10_1038_s42003_019_0402_x crossref_primary_10_1021_acsnano_9b09024 crossref_primary_10_1016_j_ymthe_2020_11_016 crossref_primary_10_1016_j_ymthe_2020_05_002 crossref_primary_10_3390_biom11101493 crossref_primary_10_1126_scitranslmed_abl9238 crossref_primary_10_1182_bloodadvances_2020003702 crossref_primary_10_1038_s41596_020_00450_9 crossref_primary_10_1038_s41565_023_01563_4 crossref_primary_10_1002_adma_202002932 crossref_primary_10_1039_D3BM00788J crossref_primary_10_1080_23808993_2020_1707077 crossref_primary_10_1039_D0TB00207K crossref_primary_10_1371_journal_pbio_3002680 crossref_primary_10_3389_fnmol_2018_00221 crossref_primary_10_1002_mgg3_394 crossref_primary_10_1016_j_bsheal_2022_03_010 crossref_primary_10_1074_jbc_RA118_004554 crossref_primary_10_3390_polym13193307 crossref_primary_10_1089_biores_2018_0017 crossref_primary_10_1097_MOO_0000000000000477 crossref_primary_10_3390_polym16182629 crossref_primary_10_1016_j_ymthe_2020_11_009 crossref_primary_10_1016_j_biomaterials_2018_04_031 crossref_primary_10_1002_advs_202100540 crossref_primary_10_1038_s41551_021_00759_0 crossref_primary_10_1016_j_neulet_2019_134527 crossref_primary_10_1093_pcmedi_pbab014 crossref_primary_10_1146_annurev_neuro_070918_050509 crossref_primary_10_1371_journal_pone_0239411 crossref_primary_10_1016_j_matt_2020_09_020 crossref_primary_10_1093_hmg_ddab153 crossref_primary_10_1038_s41434_020_0155_7 crossref_primary_10_1186_s43556_023_00115_5 crossref_primary_10_1016_j_scr_2020_101982 crossref_primary_10_1038_s41587_019_0186_z crossref_primary_10_1038_s41422_022_00624_y crossref_primary_10_1002_advs_202306788 crossref_primary_10_1002_ar_24107 crossref_primary_10_1039_D1BM00537E crossref_primary_10_3389_fmed_2021_698521 crossref_primary_10_2147_IJN_S424872 crossref_primary_10_1016_j_mattod_2018_12_003 crossref_primary_10_1056_NEJMcibr1716789 crossref_primary_10_1038_s41467_020_17029_3 crossref_primary_10_1038_s41434_023_00384_3 crossref_primary_10_1016_j_jgg_2023_07_007 crossref_primary_10_1177_20406223221104987 crossref_primary_10_1002_stem_3353 crossref_primary_10_1038_s41587_020_0561_9 crossref_primary_10_1016_j_cell_2022_03_045 crossref_primary_10_1016_j_preteyeres_2021_100975 crossref_primary_10_1101_cshperspect_a033191 crossref_primary_10_1038_s41551_024_01235_1 crossref_primary_10_1016_j_celrep_2022_111061 crossref_primary_10_1080_17425247_2023_2200246 crossref_primary_10_1038_s41551_024_01296_2 crossref_primary_10_1093_bioinformatics_bty558 crossref_primary_10_1016_j_ymthe_2019_02_012 crossref_primary_10_1016_j_jacbts_2021_11_004 crossref_primary_10_1002_advs_201902552 crossref_primary_10_1080_1061186X_2023_2216900 crossref_primary_10_1038_s41467_020_18391_y crossref_primary_10_1021_acsnano_0c04707 crossref_primary_10_3389_fphar_2023_1207141 crossref_primary_10_1016_j_heares_2022_108523 crossref_primary_10_1016_j_nano_2023_102711 crossref_primary_10_1089_crispr_2022_0051 crossref_primary_10_26508_lsa_202201592 crossref_primary_10_1021_acsbiomaterials_9b00445 crossref_primary_10_1016_j_biomaterials_2019_119711 crossref_primary_10_1038_s41591_019_0500_9 crossref_primary_10_1002_advs_202305682 crossref_primary_10_3390_jcm12030738 crossref_primary_10_1038_s41467_019_12449_2 crossref_primary_10_1016_j_cis_2019_03_007 crossref_primary_10_1038_s41576_023_00597_7 crossref_primary_10_1002_cac2_12366 crossref_primary_10_1002_smll_202100546 crossref_primary_10_1021_acs_analchem_0c04445 crossref_primary_10_3390_ma15113780 crossref_primary_10_1002_psc_3592 crossref_primary_10_3757_jser_78_219 crossref_primary_10_18632_aging_202936 crossref_primary_10_1016_j_ymthe_2018_12_014 crossref_primary_10_1038_s41578_019_0145_9 crossref_primary_10_1002_advs_201903432 crossref_primary_10_1007_s00018_023_04794_9 crossref_primary_10_1007_s40291_024_00759_1 crossref_primary_10_28982_josam_906773 crossref_primary_10_3389_fcell_2020_567682 crossref_primary_10_1155_2020_8841522 crossref_primary_10_1038_s41576_018_0059_1 crossref_primary_10_1089_crispr_2018_29002_gbu crossref_primary_10_1007_s11060_025_04995_1 crossref_primary_10_1016_j_gene_2020_144677 crossref_primary_10_1039_C9CC00010K crossref_primary_10_1016_j_jconrel_2023_12_050 crossref_primary_10_5319_wjo_v11_i1_1 crossref_primary_10_1016_j_jconrel_2021_08_015 crossref_primary_10_1016_j_omtn_2024_102345 crossref_primary_10_1017_S0022215119001531 crossref_primary_10_1016_j_apsb_2021_05_020 crossref_primary_10_1016_j_biomaterials_2019_119291 crossref_primary_10_3390_jcm12031046 crossref_primary_10_3390_life13091858 crossref_primary_10_1093_chemse_bjaa038 crossref_primary_10_1016_j_mattod_2023_04_011 crossref_primary_10_1038_s41467_018_08264_w crossref_primary_10_1016_j_isci_2019_100789 crossref_primary_10_1360_SSV_2024_0031 crossref_primary_10_3389_fncel_2019_00008 crossref_primary_10_1016_j_heares_2024_109151 crossref_primary_10_1097_JBR_0000000000000060 crossref_primary_10_3389_fgeed_2020_613252 crossref_primary_10_1126_science_add8643 crossref_primary_10_1186_s12935_023_02940_8 crossref_primary_10_3390_genes14020483 crossref_primary_10_1111_jnc_15168 crossref_primary_10_3389_fnmol_2018_00300 crossref_primary_10_1121_1_5132709 crossref_primary_10_1186_s13287_023_03617_9 crossref_primary_10_1016_j_ymthe_2020_09_032 crossref_primary_10_1016_j_pharmthera_2019_05_003 crossref_primary_10_3389_fncel_2020_00183 crossref_primary_10_1002_lary_31179 crossref_primary_10_3389_fimmu_2023_1111777 crossref_primary_10_1242_dmm_050088 crossref_primary_10_1021_acs_bioconjchem_0c00295 crossref_primary_10_1088_1361_6528_ac842d crossref_primary_10_1515_medgen_2020_2022 crossref_primary_10_1152_physrev_00053_2017 crossref_primary_10_1515_medgen_2020_2021 crossref_primary_10_1007_s00439_024_02694_x crossref_primary_10_1016_j_heares_2020_107999 crossref_primary_10_1016_j_ymthe_2023_02_001 crossref_primary_10_1186_s13068_019_1401_3 crossref_primary_10_1021_jacs_9b11638 crossref_primary_10_1080_21695717_2020_1807261 crossref_primary_10_1002_smll_202106591 crossref_primary_10_1007_s00439_021_02364_2 crossref_primary_10_1016_j_heares_2018_12_002 crossref_primary_10_1016_j_jgg_2023_08_001 crossref_primary_10_1038_s41591_018_0209_1 crossref_primary_10_1021_acsami_1c02122 crossref_primary_10_1002_jgm_3107 crossref_primary_10_1021_jacs_2c01760 crossref_primary_10_1186_s40359_023_01348_3 crossref_primary_10_1016_j_jconrel_2020_07_033 crossref_primary_10_1016_j_neurol_2018_04_006 crossref_primary_10_3389_fphar_2024_1328460 crossref_primary_10_1016_j_ebiom_2020_103171 crossref_primary_10_3390_brainsci10100756 crossref_primary_10_1038_s41573_019_0046_z crossref_primary_10_1093_hmg_ddz129 crossref_primary_10_1038_s41587_020_00781_8 crossref_primary_10_1016_j_tibtech_2018_03_004 crossref_primary_10_1002_cmdc_202400038 crossref_primary_10_1038_s41392_022_00893_4 crossref_primary_10_3390_cancers11091260 crossref_primary_10_1038_s41434_021_00240_2 crossref_primary_10_1016_j_sna_2019_05_043 crossref_primary_10_1002_ana_27053 crossref_primary_10_1126_sciadv_abh2358 crossref_primary_10_1038_s41467_018_04580_3 crossref_primary_10_1002_stem_3315 crossref_primary_10_1002_adma_201901187 crossref_primary_10_1007_s13353_019_00535_6 crossref_primary_10_1208_s12249_024_02834_6 crossref_primary_10_3390_ijms24065695 crossref_primary_10_1002_advs_202402166 crossref_primary_10_1089_crispr_2018_0037 crossref_primary_10_1186_s12920_023_01766_7 crossref_primary_10_1002_lio2_633 crossref_primary_10_1007_s13311_019_00729_0 crossref_primary_10_1016_j_ymthe_2018_10_009 crossref_primary_10_1016_j_omtm_2019_02_008 crossref_primary_10_1073_pnas_1811276115 crossref_primary_10_3390_audiolres14020022 crossref_primary_10_1016_j_cej_2022_134992 crossref_primary_10_5604_01_3001_0054_5439 crossref_primary_10_15252_emmm_202215798 crossref_primary_10_1007_s10162_020_00781_0 crossref_primary_10_1016_j_heares_2023_108919 crossref_primary_10_1039_D3AY02147E crossref_primary_10_1002_advs_202306201 crossref_primary_10_3390_ijms23073976 crossref_primary_10_3389_fbioe_2023_1211798 crossref_primary_10_1021_acsptsci_3c00324 crossref_primary_10_1089_hum_2022_062 crossref_primary_10_1155_2020_2908182 crossref_primary_10_3950_jibiinkoka_122_1508 crossref_primary_10_1080_15476286_2021_1874161 crossref_primary_10_1038_s41551_020_00656_y crossref_primary_10_1038_s41467_022_28028_x crossref_primary_10_1038_s41573_020_0084_6 crossref_primary_10_3950_jibiinkotokeibu_125_6_953 crossref_primary_10_1016_j_otoeng_2020_06_009 crossref_primary_10_18632_aging_102246 crossref_primary_10_1016_j_cobme_2018_08_002 crossref_primary_10_1038_s41434_020_0177_1 crossref_primary_10_1002_adhm_201800996 crossref_primary_10_3389_fneur_2020_00290 crossref_primary_10_1002_INMD_20220014 crossref_primary_10_1073_pnas_2307355120 crossref_primary_10_3389_fgeed_2021_737632 crossref_primary_10_3389_fnins_2023_1177791 crossref_primary_10_1016_j_ijbiomac_2024_137708 crossref_primary_10_1080_14712598_2022_2072208 crossref_primary_10_1093_nar_gkae761 |
Cites_doi | 10.1007/s00424-014-1582-3 10.1038/gt.2012.51 10.1126/science.aad5725 10.1002/ar.22579 10.1007/s10162-017-0634-8 10.1073/pnas.1520244113 10.1016/j.ajhg.2016.03.028 10.1038/ng848 10.1038/nbt.3081 10.1038/nbt.3117 10.1038/nbt.3469 10.1126/science.1241062 10.1101/gr.171322.113 10.1056/NEJMra050700 10.1038/nbt.2673 10.1002/ajmg.1320460504 10.1016/S1567-133X(03)00089-9 10.1038/nbt.3801 10.1038/nbt.3471 10.1016/j.cell.2016.10.044 10.1371/journal.pone.0097064 10.1038/ng842 10.1038/nbt.2808 10.1523/JNEUROSCI.1489-13.2013 10.1038/nrd4533 10.1016/j.neuron.2013.06.019 10.1038/nm.3106 |
ContentType | Journal Article |
Copyright | Macmillan Publishers Limited, part of Springer Nature. All rights reserved. 2018 COPYRIGHT 2018 Nature Publishing Group Copyright Nature Publishing Group Jan 11, 2018 |
Copyright_xml | – notice: Macmillan Publishers Limited, part of Springer Nature. All rights reserved. 2018 – notice: COPYRIGHT 2018 Nature Publishing Group – notice: Copyright Nature Publishing Group Jan 11, 2018 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QG 7QL 7QP 7QR 7RV 7SN 7SS 7ST 7T5 7TG 7TK 7TM 7TO 7U9 7X2 7X7 7XB 88A 88E 88G 88I 8AF 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK 8G5 ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BEC BENPR BGLVJ BHPHI BKSAR C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M2M M2O M2P M7N M7P M7S MBDVC NAPCQ P5Z P62 P64 PATMY PCBAR PDBOC PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ PTHSS PYCSY Q9U R05 RC3 S0X SOI 7X8 5PM |
DOI | 10.1038/nature25164 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Meteorological & Geoastrophysical Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest SciTech Premium Collection Technology Collection Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central Technology Collection Natural Science Collection Earth, Atmospheric & Aquatic Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Collection (ProQuest) ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database Health & Medical Collection (Alumni) Medical Database Psychology Database Research Library Science Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database (ProQuest) Engineering Database Research Library (Corporate) Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Earth, Atmospheric & Aquatic Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology Engineering collection Environmental Science Collection ProQuest Central Basic University of Michigan Genetics Abstracts SIRS Editorial Environment Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database ProQuest One Psychology Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts elibrary ProQuest AP Science SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Earth, Atmospheric & Aquatic Science Database Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) University of Michigan Technology Collection Technology Research Database ProQuest One Academic Middle East (New) SIRS Editorial Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central Earth, Atmospheric & Aquatic Science Collection ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Research Library ProQuest Materials Science Collection ProQuest Public Health ProQuest Central Basic ProQuest Science Journals ProQuest Nursing & Allied Health Source ProQuest Psychology Journals (Alumni) ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library ProQuest Psychology Journals Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Agricultural Science Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) Physics |
EISSN | 1476-4687 |
EndPage | 221 |
ExternalDocumentID | PMC5784267 A522392874 29258297 10_1038_nature25164 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: R35 GM118062 – fundername: NIDCD NIH HHS grantid: R01 DC013521 – fundername: NIDCD NIH HHS grantid: P30 DC005209 – fundername: NIDCD NIH HHS grantid: F32 DC000138 – fundername: Howard Hughes Medical Institute – fundername: NIDCD NIH HHS grantid: R01 DC000188 – fundername: NIDCD NIH HHS grantid: R01 DC009836 – fundername: NICHD NIH HHS grantid: U54 HD090255 – fundername: NIDCD NIH HHS grantid: R01 DC006908 – fundername: NIBIB NIH HHS grantid: R01 EB022376 |
GroupedDBID | --- --Z -DZ -ET -~X .55 .CO .XZ 07C 0R~ 0WA 123 186 1OL 1VR 29M 2KS 2XV 39C 3V. 41X 53G 5RE 6TJ 70F 7RV 7X2 7X7 7XC 85S 88A 88E 88I 8AF 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ 8G5 8R4 8R5 8WZ 97F 97L A6W A7Z AAEEF AAHBH AAHTB AAIKC AAKAB AAMNW AASDW AAYEP AAYZH AAZLF ABDQB ABFSI ABIVO ABJCF ABJNI ABLJU ABOCM ABPEJ ABPPZ ABUWG ABWJO ABZEH ACBEA ACBWK ACGFO ACGFS ACGOD ACIWK ACKOT ACMJI ACNCT ACPRK ACWUS ADBBV ADFRT ADUKH AENEX AEUYN AFFNX AFKRA AFLOW AFRAH AFSHS AGAYW AGHSJ AGHTU AGNAY AGSOS AHMBA AHSBF AIDAL AIDUJ ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH ARAPS ARMCB ASPBG ATCPS ATWCN AVWKF AXYYD AZFZN AZQEC BBNVY BCU BEC BENPR BGLVJ BHPHI BIN BKEYQ BKKNO BKSAR BPHCQ BVXVI CCPQU CJ0 CS3 D1I D1J D1K DU5 DWQXO E.- E.L EAP EBS EE. EJD EMH EPS ESX EX3 EXGXG F5P FEDTE FQGFK FSGXE FYUFA GNUQQ GUQSH HCIFZ HG6 HMCUK HVGLF HZ~ I-F IAO ICQ IEA IEP IGS IH2 IHR INH INR IOF IPY ISR ITC K6- KB. KOO L6V L7B LK5 LK8 LSO M0K M0L M1P M2M M2O M2P M7P M7R M7S N9A NAPCQ NEJ NEPJS O9- OBC OES OHH OMK OVD P2P P62 PATMY PCBAR PDBOC PKN PQQKQ PROAC PSQYO PSYQQ PTHSS PYCSY Q2X R05 RND RNS RNT RNTTT RXW S0X SC5 SHXYY SIXXV SJFOW SJN SNYQT SOJ SV3 TAE TAOOD TBHMF TDRGL TEORI TN5 TSG TWZ U5U UIG UKHRP UKR UMD UQL VQA VVN WH7 WOW X7M XIH XKW XZL Y6R YAE YCJ YFH YIF YIN YNT YOC YQT YR2 YR5 YXB YZZ Z5M ZCA ZE2 ~02 ~7V ~88 ~KM AARCD AAYXX ABFSG ACMFV ACSTC ADXHL AETEA AFANA ALPWD ATHPR CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB AEIIB PMFND 7QG 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7TG 7TK 7TM 7TO 7U9 7XB 8FD 8FK C1K FR3 H94 K9. KL. M7N MBDVC P64 PKEHL PQEST PQUKI PRINS Q9U RC3 SOI 7X8 5PM TUS |
ID | FETCH-LOGICAL-c678t-e9191bb27046ce0d306e60c433b1a64dad61166e94f93fa04706af7317afc32c3 |
IEDL.DBID | 8FG |
ISSN | 0028-0836 1476-4687 |
IngestDate | Thu Aug 21 18:24:55 EDT 2025 Fri Jul 11 16:22:29 EDT 2025 Fri Jul 25 09:12:04 EDT 2025 Tue Jun 17 22:05:26 EDT 2025 Fri Jun 13 00:12:13 EDT 2025 Tue Jun 10 15:35:25 EDT 2025 Tue Jun 10 21:06:33 EDT 2025 Fri Jun 27 05:57:24 EDT 2025 Mon Jul 21 06:05:30 EDT 2025 Tue Jul 01 00:57:10 EDT 2025 Thu Apr 24 23:11:38 EDT 2025 Fri Feb 21 02:38:43 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7687 |
Language | English |
License | Reprints and permissions information is available at www.nature.com/reprints Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c678t-e9191bb27046ce0d306e60c433b1a64dad61166e94f93fa04706af7317afc32c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Current address: Department of Chemical and Biomolecular Engineering, Rice University, Houston, Texas 77005, USA These authors contributed equally to this work Current address: Department of Otolaryngology-Head and Neck Surgery, Shanghai Ninth People’s Hospital and Ear Institute, Shanghai Jiaotong University School of Medicine, Shanghai, 200011, China |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC5784267 |
PMID | 29258297 |
PQID | 1987371515 |
PQPubID | 40569 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5784267 proquest_miscellaneous_1979171552 proquest_journals_1987371515 gale_infotracmisc_A522392874 gale_infotracgeneralonefile_A522392874 gale_infotraccpiq_522392874 gale_infotracacademiconefile_A522392874 gale_incontextgauss_ISR_A522392874 pubmed_primary_29258297 crossref_primary_10_1038_nature25164 crossref_citationtrail_10_1038_nature25164 springer_journals_10_1038_nature25164 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-01-11 |
PublicationDateYYYYMMDD | 2018-01-11 |
PublicationDate_xml | – month: 01 year: 2018 text: 2018-01-11 day: 11 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationSubtitle | International weekly journal of science |
PublicationTitle | Nature (London) |
PublicationTitleAbbrev | Nature |
PublicationTitleAlternate | Nature |
PublicationYear | 2018 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Lentz (CR25) 2013; 19 Marazita (CR2) 1993; 46 CR17 Komor, Badran, Liu (CR10) 2017; 168 Lumpkin (CR28) 2003; 3 Vreugde (CR21) 2002; 30 Kurima (CR19) 2002; 30 Ahmed, Shubina-Oleinik, Holt (CR8) 2017; 18 Kim, Kim, Cho, Kim, Kim (CR14) 2014; 24 Pan (CR7) 2017; 35 Angeli, Lin, Liu (CR1) 2012; 295 Morton, Nance (CR3) 2006; 354 Tsai (CR23) 2015; 33 Long (CR11) 2016; 351 Yin (CR13) 2016; 34 Zuris (CR15) 2015; 33 Zhao (CR18) 2014; 9 Müller, Barr-Gillespie (CR5) 2015; 14 Géléoc, Holt (CR4) 2014; 344 CR24 Huang, Kantardzhieva, Scheffer, Liberman, Chen (CR29) 2013; 33 Yang (CR12) 2016; 34 Pan (CR16) 2013; 79 Pattanayak (CR27) 2013; 31 Kawashima, Kurima, Pan, Griffith, Holt (CR20) 2015; 467 Fu, Sander, Reyon, Cascio, Joung (CR22) 2014; 32 Sacheli, Delacroix, Vandenackerveken, Nguyen, Malgrange (CR9) 2013; 20 Shibata (CR6) 2016; 98 Wang (CR26) 2016; 113 ML Marazita (BFnature25164_CR2) 1993; 46 H Ahmed (BFnature25164_CR8) 2017; 18 BFnature25164_CR17 JJ Lentz (BFnature25164_CR25) 2013; 19 B Pan (BFnature25164_CR16) 2013; 79 S Vreugde (BFnature25164_CR21) 2002; 30 CC Morton (BFnature25164_CR3) 2006; 354 Y Zhao (BFnature25164_CR18) 2014; 9 H Yin (BFnature25164_CR13) 2016; 34 S Kim (BFnature25164_CR14) 2014; 24 Y Kawashima (BFnature25164_CR20) 2015; 467 S Angeli (BFnature25164_CR1) 2012; 295 U Müller (BFnature25164_CR5) 2015; 14 C Long (BFnature25164_CR11) 2016; 351 SQ Tsai (BFnature25164_CR23) 2015; 33 Y Yang (BFnature25164_CR12) 2016; 34 JA Zuris (BFnature25164_CR15) 2015; 33 EA Lumpkin (BFnature25164_CR28) 2003; 3 AC Komor (BFnature25164_CR10) 2017; 168 B Pan (BFnature25164_CR7) 2017; 35 Y Fu (BFnature25164_CR22) 2014; 32 M Huang (BFnature25164_CR29) 2013; 33 K Kurima (BFnature25164_CR19) 2002; 30 BFnature25164_CR24 GS Géléoc (BFnature25164_CR4) 2014; 344 R Sacheli (BFnature25164_CR9) 2013; 20 M Wang (BFnature25164_CR26) 2016; 113 SB Shibata (BFnature25164_CR6) 2016; 98 V Pattanayak (BFnature25164_CR27) 2013; 31 29323325 - Nature. 2018 Jan 11;553(7687):162-163. doi: 10.1038/d41586-017-08645-z. 29293216 - Nature. 2017 Dec 21;552(7685):300-301. doi: 10.1038/d41586-017-08722-3. |
References_xml | – volume: 467 start-page: 85 year: 2015 end-page: 94 ident: CR20 article-title: Transmembrane channel-like (TMC) genes are required for auditory and vestibular mechanosensation publication-title: Pflugers Arch. doi: 10.1007/s00424-014-1582-3 – volume: 20 start-page: 237 year: 2013 end-page: 247 ident: CR9 article-title: Gene transfer in inner ear cells: a challenging race publication-title: Gene Ther. doi: 10.1038/gt.2012.51 – volume: 351 start-page: 400 year: 2016 end-page: 403 ident: CR11 article-title: Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy publication-title: Science doi: 10.1126/science.aad5725 – volume: 295 start-page: 1812 year: 2012 end-page: 1829 ident: CR1 article-title: Genetics of hearing and deafness publication-title: Anat. Rec. (Hoboken) doi: 10.1002/ar.22579 – volume: 18 start-page: 649 year: 2017 end-page: 670 ident: CR8 article-title: Emerging gene therapies for genetic hearing loss publication-title: J. Assoc. Res. Otolaryngol. doi: 10.1007/s10162-017-0634-8 – volume: 113 start-page: 2868 year: 2016 end-page: 2873 ident: CR26 article-title: Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1520244113 – volume: 98 start-page: 1101 year: 2016 end-page: 1113 ident: CR6 article-title: RNA interference prevents autosomal-dominant hearing loss publication-title: Am. J. Hum. Genet. doi: 10.1016/j.ajhg.2016.03.028 – volume: 30 start-page: 257 year: 2002 end-page: 258 ident: CR21 article-title: Beethoven, a mouse model for dominant, progressive hearing loss DFNA36 publication-title: Nat. Genet. doi: 10.1038/ng848 – volume: 33 start-page: 73 year: 2015 end-page: 80 ident: CR15 article-title: Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing and publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3081 – volume: 33 start-page: 187 year: 2015 end-page: 197 ident: CR23 article-title: GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3117 – volume: 34 start-page: 334 year: 2016 end-page: 338 ident: CR12 article-title: A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3469 – volume: 344 start-page: 1241062 year: 2014 ident: CR4 article-title: Sound strategies for hearing restoration publication-title: Science doi: 10.1126/science.1241062 – volume: 24 start-page: 1012 year: 2014 end-page: 1019 ident: CR14 article-title: Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins publication-title: Genome Res. doi: 10.1101/gr.171322.113 – volume: 354 start-page: 2151 year: 2006 end-page: 2164 ident: CR3 article-title: Newborn hearing screening—a silent revolution publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra050700 – volume: 31 start-page: 839 year: 2013 end-page: 843 ident: CR27 article-title: High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2673 – volume: 46 start-page: 486 year: 1993 end-page: 491 ident: CR2 article-title: Genetic epidemiological studies of early-onset deafness in the U.S. school-age population publication-title: Am. J. Med. Genet. doi: 10.1002/ajmg.1320460504 – volume: 3 start-page: 389 year: 2003 end-page: 395 ident: CR28 article-title: Math1-driven GFP expression in the developing nervous system of transgenic mice publication-title: Gene Expr. Patterns doi: 10.1016/S1567-133X(03)00089-9 – volume: 35 start-page: 264 year: 2017 end-page: 272 ident: CR7 article-title: Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3801 – volume: 34 start-page: 328 year: 2016 end-page: 333 ident: CR13 article-title: Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3471 – ident: CR17 – volume: 168 start-page: 20 year: 2017 end-page: 36 ident: CR10 article-title: CRISPR-based technologies for the manipulation of eukaryotic genomes publication-title: Cell doi: 10.1016/j.cell.2016.10.044 – volume: 9 start-page: e97064 year: 2014 ident: CR18 article-title: A novel DFNA36 mutation in TMC1 orthologous to the Beethoven (Bth) mouse associated with autosomal dominant hearing loss in a Chinese family publication-title: PLoS One doi: 10.1371/journal.pone.0097064 – volume: 30 start-page: 277 year: 2002 end-page: 284 ident: CR19 article-title: Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function publication-title: Nat. Genet. doi: 10.1038/ng842 – volume: 32 start-page: 279 year: 2014 end-page: 284 ident: CR22 article-title: Improving CRISPR-Cas nuclease specificity using truncated guide RNAs publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2808 – volume: 33 start-page: 15086 year: 2013 end-page: 15094 ident: CR29 article-title: Hair cell overexpression of Islet1 reduces age-related and noise-induced hearing loss publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1489-13.2013 – volume: 14 start-page: 346 year: 2015 end-page: 365 ident: CR5 article-title: New treatment options for hearing loss publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4533 – ident: CR24 – volume: 79 start-page: 504 year: 2013 end-page: 515 ident: CR16 article-title: TMC1 and TMC2 are components of the mechanotransduction channel in hair cells of the mammalian inner ear publication-title: Neuron doi: 10.1016/j.neuron.2013.06.019 – volume: 19 start-page: 345 year: 2013 end-page: 350 ident: CR25 article-title: Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness publication-title: Nat. Med. doi: 10.1038/nm.3106 – volume: 79 start-page: 504 year: 2013 ident: BFnature25164_CR16 publication-title: Neuron doi: 10.1016/j.neuron.2013.06.019 – volume: 33 start-page: 187 year: 2015 ident: BFnature25164_CR23 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3117 – volume: 467 start-page: 85 year: 2015 ident: BFnature25164_CR20 publication-title: Pflugers Arch. doi: 10.1007/s00424-014-1582-3 – volume: 35 start-page: 264 year: 2017 ident: BFnature25164_CR7 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3801 – volume: 46 start-page: 486 year: 1993 ident: BFnature25164_CR2 publication-title: Am. J. Med. Genet. doi: 10.1002/ajmg.1320460504 – volume: 295 start-page: 1812 year: 2012 ident: BFnature25164_CR1 publication-title: Anat. Rec. (Hoboken) doi: 10.1002/ar.22579 – volume: 344 start-page: 1241062 year: 2014 ident: BFnature25164_CR4 publication-title: Science doi: 10.1126/science.1241062 – volume: 113 start-page: 2868 year: 2016 ident: BFnature25164_CR26 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1520244113 – volume: 34 start-page: 328 year: 2016 ident: BFnature25164_CR13 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3471 – volume: 14 start-page: 346 year: 2015 ident: BFnature25164_CR5 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4533 – volume: 19 start-page: 345 year: 2013 ident: BFnature25164_CR25 publication-title: Nat. Med. doi: 10.1038/nm.3106 – volume: 32 start-page: 279 year: 2014 ident: BFnature25164_CR22 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2808 – volume: 354 start-page: 2151 year: 2006 ident: BFnature25164_CR3 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra050700 – volume: 24 start-page: 1012 year: 2014 ident: BFnature25164_CR14 publication-title: Genome Res. doi: 10.1101/gr.171322.113 – volume: 20 start-page: 237 year: 2013 ident: BFnature25164_CR9 publication-title: Gene Ther. doi: 10.1038/gt.2012.51 – volume: 9 start-page: e97064 year: 2014 ident: BFnature25164_CR18 publication-title: PLoS One doi: 10.1371/journal.pone.0097064 – ident: BFnature25164_CR17 – volume: 3 start-page: 389 year: 2003 ident: BFnature25164_CR28 publication-title: Gene Expr. Patterns doi: 10.1016/S1567-133X(03)00089-9 – volume: 30 start-page: 277 year: 2002 ident: BFnature25164_CR19 publication-title: Nat. Genet. doi: 10.1038/ng842 – volume: 33 start-page: 15086 year: 2013 ident: BFnature25164_CR29 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1489-13.2013 – volume: 351 start-page: 400 year: 2016 ident: BFnature25164_CR11 publication-title: Science doi: 10.1126/science.aad5725 – volume: 168 start-page: 20 year: 2017 ident: BFnature25164_CR10 publication-title: Cell doi: 10.1016/j.cell.2016.10.044 – volume: 34 start-page: 334 year: 2016 ident: BFnature25164_CR12 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3469 – volume: 30 start-page: 257 year: 2002 ident: BFnature25164_CR21 publication-title: Nat. Genet. doi: 10.1038/ng848 – ident: BFnature25164_CR24 – volume: 98 start-page: 1101 year: 2016 ident: BFnature25164_CR6 publication-title: Am. J. Hum. Genet. doi: 10.1016/j.ajhg.2016.03.028 – volume: 31 start-page: 839 year: 2013 ident: BFnature25164_CR27 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2673 – volume: 18 start-page: 649 year: 2017 ident: BFnature25164_CR8 publication-title: J. Assoc. Res. Otolaryngol. doi: 10.1007/s10162-017-0634-8 – volume: 33 start-page: 73 year: 2015 ident: BFnature25164_CR15 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3081 – reference: 29323325 - Nature. 2018 Jan 11;553(7687):162-163. doi: 10.1038/d41586-017-08645-z. – reference: 29293216 - Nature. 2017 Dec 21;552(7685):300-301. doi: 10.1038/d41586-017-08722-3. |
SSID | ssj0005174 |
Score | 2.664997 |
Snippet | CRISPR–Cas9 genome editing is used to correct a dominant-negative mutation in a mouse model of inherited deafness, resulting in improvements in cochlear... Although genetic factors contribute to almost half of all cases of deafness, treatment options for genetic deafness are limited. We developed a genome-editing... Although genetic factors contribute to almost half of all cases of deafness, treatment options for genetic deafness are limited1-5. We developed a... Although genetic factors contribute to almost half of all deafness cases, treatment options for genetic deafness are limited 1 – 5 . We developed a genome... |
SourceID | pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 217 |
SubjectTerms | 45 45/41 631/1647/1511 631/61/2297 Acoustic startle response Acoustic Stimulation Alleles Animals Animals, Newborn Auditory Threshold Autosomal dominant inheritance Base Sequence Brain stem Care and treatment Cell Survival Cochlea Cochlea - cytology Cochlea - metabolism CRISPR CRISPR-Associated Proteins - administration & dosage CRISPR-Associated Proteins - metabolism CRISPR-Associated Proteins - therapeutic use CRISPR-Cas Systems Deafness Deoxyribonucleic acid Disease Models, Animal DNA Ears & hearing Evoked Potentials, Auditory, Brain Stem Female Fibroblasts Gene Editing - methods Gene therapy Genes Genes, Dominant - genetics Genetic disorders Genetic engineering Genetic factors Genetic Therapy - methods Genome editing Genomes Hair Cells, Auditory - cytology Hearing loss Hearing Loss - genetics Hearing Loss - physiopathology Hearing Loss - prevention & control Humanities and Social Sciences Humans letter Lipids Liposomes Male Membrane Proteins - genetics Methods Mice multidisciplinary Mutation Neonates Proteins Reflex, Startle Ribonucleic acid RNA Science Survival |
Title | Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents |
URI | https://link.springer.com/article/10.1038/nature25164 https://www.ncbi.nlm.nih.gov/pubmed/29258297 https://www.proquest.com/docview/1987371515 https://www.proquest.com/docview/1979171552 https://pubmed.ncbi.nlm.nih.gov/PMC5784267 |
Volume | 553 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB4VUKVeqkJfKXTlVvQpRSRxcOJTRRFbWqmooiBtT5bjOHSlJVmaXST-fWcSZ9lsUS-5eJxYHnsemc-fAXZFYNKMx9KPUiLVDvPYT4WVaAyFkRqToqCgRPH7iTg-j7-N9kfuh1vtYJWdTWwMdV4Z-ke-R8kxT8j9fppe-XRrFFVX3RUaa7ARoqchSFc6_HIL8VhhYXbn8wKe7rW0mejcRdzzSKt2eckxrYImVyqnjUMaPoKHLpJkB63qN-GeLbfgfoPoNPUWbLpdW7P3jlr6w2P4ddbhyllVMD2fVXV1iS_JqxYRw-h-a_wam-BIWXbDxiW7Hl9XLLcTAnDcUDeidb20DL0eQaaZpsNZ9RM4Hx6dHR777nIF36B_mvlWYqaWZVGCCbKxQY6pg0XFxZxnoRZxrnMRhgLVFheSFzqIk0DoIsFwQxeGR4Y_hfWyKu1zYIJqj5IHMsVYIZKZpFqOzgudoyxaRA8-dhOsjGMepwswJqqpgPNULWnDg92F8LQl3Lhb7DVpShGFRUkYmQs9r2v19eepOsCQEqO-NEGhd06oqPCDRrsjBzhsYr3qSW73JM10fKWWWt_2Wi9atd31mp2eIG5V02_u1pVypqJWtwvbg1eLZupJ8LfSVnOSSTCtJrY8D561y3AxOZGM9ul8tAdJb4EuBIhAvN9Sjn83ROJorTFAw55vuqW8NKx_5_zF_4e_DQ8wmiRopB-GO7A--zO3LzFim2UDWEtGCT7Tw3DQbNEBbHw-Ovlx-hfG90H5 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgQXRMujoQUMaqFUiprEaRIfEKqAZZc-DrCVysk4jlNW2iZbslu0f4rfyEwe281ScevZn52RPZ5HPP4MsBk4Ooq5L2wvIlJtN_HtKDACjWGghcKkyEkpUTw6Dron_pfTvdMl-NPchaGyysYmloY6yTX9I9-l5JiH5H7fjy5sejWKTlebJzQqtTgw09-YshXveh9xfbc8r_Op_6Fr168K2BoN89g2AlOUOPZCzAy1cRKMmQ1K7HMeuyrwE5UErhugvH4qeKocP3QClYboZ1Wquac5jnsLbiNeULIXdT5flZQssD7X9wEdHu1WNJ0YTAR-ywMu-oE5R7hYpLlwUls6wM4DuF9Hrmy_UrUVWDLZKtwpK0h1sQortZUo2HZNZf32IXzvN3XsLE-ZmozzIj_HQZK8qsBh9J42fo0NUVIWT9kgY5eDy5wlZkgFI1PqRjSy54ahl6USbaboMljxCE5uZNofw3KWZ2YNWEBnnYI7IsLYxBOxoLMjlaQqQSxaYAt2mgmWumY6pwc3hrI8ceeRnFsNCzZn4FFF8HE97BWtlCTKjIxqcs7UpChk79tXuY8hLEaZUYigNzUozfGDWtVXHFBsYtlqIddbSD0aXMi51tet1rNq2a4bZqMFRNOg282NXsnaNBXyaiNZ8HLWTD2p3C4z-YQwIabxxM5nwZNKDWeT4wlvj-5jWxC2FHQGIMLydks2-FkSl6N3wIAQe241qjwn1r9z_vT_4r-Au93-0aE87B0frMM9jGSpLNN23Q1YHv-amGcYLY7j5-UWZfDjpm3CX-RHet0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlAviJZHQwsY1PKSok3iNIkPCFUtqy6FCkErlZNxHKestE22ZLdo_xq_jpk8lmSpuPXssTOyx_OIP38G2AocHcXcF7YXEam2m_h2FBiBzjDQQmFR5KRUKH46Cg5O_A-nO6dL8Lu5C0OwysYnlo46yTX9I-9RccxDCr-9tIZFfN7vvxtf2PSCFJ20Ns9pVCZyaGa_sHwr3g72ca23Pa___njvwK5fGLA1OumJbQSWK3HshVglauMkmD8b1N7nPHZV4CcqCVw3QN39VPBUOX7oBCoNMeaqVHNPcxz3BtxExSLaY9FeC16ywABd3w10eNSrKDsxsQj8TjRcjAmtoLgI2Fw4tS2DYf8u3KmzWLZbmd0qLJlsDW6VaFJdrMFq7TEK9qqmtX59D74dN5h2lqdMTSd5kZ_jIEleoXEYva2NX2Mj1JTFMzbM2OXwMmeJGRF4ZEbdiFL23DCMuATXZoouhhX34eRapv0BLGd5ZtaBBXTuKbgjIsxTPBELOkdSSaoSlEVvbMGbZoKlrlnP6fGNkSxP33kkW6thwdZceFyRfVwt9pxWShJ9RkaGeKamRSEHX7_IXUxnMeOMQhR6WQulOX5Qq_q6A6pNjFsdyY2OpB4PL2Sr9UWn9axatquG2ewIopvQ3ebGrmTtpgr5d1NZ8GzeTD0JepeZfEoyIZb0xNRnwcPKDOeT4wlvh-5mWxB2DHQuQOTl3ZZs-KMkMcdIgckh9txuTLml1r9z_uj_6j-F2-gN5MfB0eEGrGBSSwhN23U3YXnyc2oeY-I4iZ-UO5TB9-t2CX8ANwd-3g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+of+autosomal+dominant+hearing+loss+by+in+vivo+delivery+of+genome+editing+agents&rft.jtitle=Nature+%28London%29&rft.au=Gao%2C+Xue&rft.au=Tao%2C+Yong&rft.au=Lamas%2C+Veronica&rft.au=Huang%2C+Mingqian&rft.date=2018-01-11&rft.issn=1476-4687&rft.eissn=1476-4687&rft.volume=553&rft.issue=7687&rft.spage=217&rft_id=info:doi/10.1038%2Fnature25164&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-0836&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-0836&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-0836&client=summon |